A Phase III Trial Comparing Docetaxel Every Third Week to Biweekly Docetaxel Monotherapy in Metastatic Hormone Refractory Prostate Cancer Patients - PROSTY Trial.
Latest Information Update: 03 Oct 2021
At a glance
- Drugs Docetaxel (Primary) ; Prednisolone
- Indications Adenocarcinoma; Prostate cancer
- Focus Therapeutic Use
- Acronyms PROSTY
- Sponsors Sanofi
- 01 Oct 2019 Results assessing germline variant and docetaxel treatment reponse by using data from this study and a retrospective study published in the Anticancer Research.
- 01 Feb 2014 Results of a QOL analysis presented at the 2014 Genitourinary Cancers Symposium.
- 07 Jun 2011 Final analysis results presented at the 47th Annual Meeting of the American Society of Clinical Oncology.